CD8A and dengue disease: By leveraging T-cell epitopes, understanding the nuances of CD8+ T-cell-mediated immunity, and refining the vaccine formulation with improved adjuvants and delivery systems, we can envisage a future where dengue vaccination becomes a more potent tool in our arsenal against the disease.